A Phase 2 Study to Evaluate the Efficacy and Safety of QLS1128 Orally in Symptomatic Participants With Mild to Moderate COVID-19

Study to Evaluate the Efficacy and Safety of Oral RP7214, a DHODH Inhibitor, in Patients With Symptomatic Mild COVID-19 Infection.

NCT05007236 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Safety, Tolerability and Preliminary Efficacy of HH-120 for the Treatment of COVID-19

NCT06039163 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo

NCT04521296 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled MBS-COV (SNS812) in Healthy Participants

NCT05677893 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects

NCT06063330 ·Status: COMPLETED ·Phase: PHASE1

A Study To Assess The Efficacy and Safety of HH-120 Nasal Spray for the Treatment of Mild COVID-19

NCT05713318 ·Status: COMPLETED ·Phase: PHASE2

Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients

NCT04523181 ·Status: COMPLETED ·Phase: PHASE2

Study of RAY1216 Tablets Compared With Placebo in Patients With Mild to Moderate COVID-19

NCT05620160 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression

NCT05947812 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated Influenza

NCT05702489 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Efficacy and Safety of SA58 Nasal Spray in Close Contact With COVID-19 People

NCT05667714 ·Status: UNKNOWN ·Phase: NA

The Safety, Tolerability and Pharmacokinetic Study of ZSP1273 in Healthy Volunteers.

NCT03679143 ·Status: COMPLETED ·Phase: PHASE1

A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19

NCT05387369 ·Status: RECRUITING

Efficacy and Safety Evaluation of Paxlovid for COVID-19: a Real-world Case-control Study

NCT05532852 ·Status: UNKNOWN ·Phase: NA

Clinical Trial of Jinzhen Oral Liquid in Treating Children With COVID-19 Infection

NCT05507489 ·Status: UNKNOWN ·Phase: NA

GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)

NCT04590547 ·Status: COMPLETED ·Phase: PHASE2

GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19)

NCT04408183 ·Status: TERMINATED ·Phase: PHASE2

A Study of S-892216 in Participants With COVID-19

NCT06928051 ·Status: COMPLETED ·Phase: PHASE2

SHEN211 Tablets for the Treatment of Mild and Moderate Novel Corona Virus Infections (COVID-19)

NCT06288893 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Phase III Confirmatory Study of K-237

NCT05056883 ·Status: COMPLETED ·Phase: PHASE3

A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection

NCT05047601 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Clinical Trial of COVID-19 Vaccine（SARS-CoV-2 Variant(Omicron BA.5) mRNA Vaccine） in Participants Aged 18 Years and Over

NCT05745545 ·Status: UNKNOWN ·Phase: NA

A Study to Assess the Efficacy of HH-120 Nasal Spray for Prevention of SARS-CoV-2 Infection in Adult Close Contacts of Individuals Infected With SARS-CoV-2

NCT05765279 ·Status: COMPLETED ·Phase: NA

A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19

NCT04522830 ·Status: COMPLETED ·Phase: PHASE2

A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19

NCT05305547 ·Status: COMPLETED ·Phase: PHASE3